Prostate Cancer in the Elderly Male: Diagnostic and Management Considerations
- 66 Downloads
Purpose of Review
Along with an aging US population comes the growing need for clinical guidelines inclusive of and specific to this unique group. Prostate cancer (PCa) is increasingly recognized as a substantial cause of mortality and morbidity in the elderly. This review seeks to address the unmet need for standardized PCa screening and management protocols for geriatric men and to synthesize recommendations based on recent literature.
Guidelines regarding PCa screening in elderly men are still being optimized, with many organizations moving toward inclusion of pre-screening global health assessment. Physician compliance with screening and treatment of PCa in geriatric patients is suboptimal, despite advanced age being a predictor of advanced disease. Elderly patients may experience treatment-related side effects which differ from their younger counterparts.
Providers treating older men are encouraged to utilize comprehensive health assessments which account for comorbidities, functional status, and global well-being, along with shared decision-making, in determining diagnostic and therapeutic pathways.
KeywordsProstate cancer Aged Prostatectomy Risk assessment Surgical care Geriatric care
US Preventive Services Task Force
American Geriatric Society
American Urological Association
National Comprehensive Cancer Network
Androgen deprivation therapy
International Society of Geriatric Oncology
External beam radiation therapy
Compliance with Ethical Standards
Conflict of Interest
Marcus Quek, Kristin Baldea, and Marah Hehemann declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 3.National Cancer Institute Surveillance, Epidemiology, and End Results Program, Cancer Stat Facts:prostate cancer. 2016. https://seer.cancer.gov/statfacts/html/prost.html. Accessed 16 Dec 2016.
- 5.Wan H, Sengupta M, Velkoff VA, DeBarros KA. U.S. Census Bureau. 65+ in the United States: 2005 (Current Population Reports: p. 23–209). Washington, DC: U.S. Government Printing Office; 2005. http://www.census.gov/prod/2006pubs/p23-209.pdf.
- 13.NCCN Clinical practice guidelines in oncology: Prostate Cancer, version 2. 2017. Available from https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed 16 Jul 2017.
- 16.Peek ME. Screening mammography in the elderly: a review of the issues. J Am Med Womens Assoc. 2003;58(3):191–8.Google Scholar
- 18.• Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol. 2007;25(24):3576–81. Manuscript describing a novel nomogram for estimation of 10-year life expectancy in PCa patients undergoing definitive therapy (RP or RT), thereby identifying those patients believed to benefit most from curative treatment. PubMedCrossRefGoogle Scholar
- 19.• NCCN. Practice guidelines in oncology: older adult oncology. 2016. Oncologic practice guidelines specific to geriatric patients published by the NCCN. Includes easy-to-follow flow diagrams detailing approach to decision-making in the older adult and comprehensive geriatric assessment. Google Scholar
- 29.• Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117–23. Registry study demonstrating the propensity of older men to undergo less invasive treatment of localized PCa. PubMedPubMedCentralCrossRefGoogle Scholar
- 31.• Droz JP, Aapro M, Balducci L, et al. Management of prostate cancer in older patients: updated recommendations of a working group of the international society of geriatric oncology. Lancet Oncol. 2014;15(9):404. Most recent SIOG consensus statement on PCa describing assessment of life expectancy, comorbidities, and health status. Authors describe G8 rapid geriatric assessment instrument and stratification of treatment options by level of health impairment. CrossRefGoogle Scholar
- 40.• Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61. Prospective study demonstrating advanced age as a risk factor for treatment-related sexual, urinary, and bowel sequelae and impact of these effects on patient quality of life and partner satisfaction. PubMedCrossRefGoogle Scholar
- 42.• D'Amico AV, Chen MH, Renshaw A, Loffredo M, Kantoff PW. Long-term follow-up of a randomized trial of radiation with or without androgen deprivation therapy for localized prostate cancer. JAMA. 2015;314(12):1291–3. Randomized trial demonstrating survival benefit conferred by concomitant short-term ADT with definitive RT versus RT alone in PCa patients with minimal comorbidities. PubMedCrossRefGoogle Scholar
- 48.• Kunkler IH, Audisio R, Belkacemi Y, et al. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force. Ann Oncol. 2014;25(11):2134–46. Comprehensive review of evidence-based guidelines for RT in geriatric oncology patients, including men with PCa. PubMedCrossRefGoogle Scholar